At a glance
Shield is a de-risked commercial stage, pharmaceutical company with a focus on addressing iron deficiency.
Our clear purpose is to help our patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives.
The Group’s lead product, Ferric Maltol, is approved by the FDA and will be marketed in the US as Accrufer®. Ferric Maltol is also approved by the EMA and Swiss Medic and marketed in the European Union as Feraccru® by our commercial partner, Norgine BV.